Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of AR19 in Adult ADHD
NCT03659929Phase 3Completed
- Start
- Sep 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of amphetamine sulfate in attention deficit hyperactivity disorder (ADHD) (3 arms). Primary endpoint: Adult ADHD Investigator Symptom Rating Scale at Week 5. Started Sep 2018; status: completed.
02
Drugs
amphetamine sulfate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03659929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03659929.